Company / Interest Expense
PharmaCyte Biotech, Inc. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$509
FY2023
5-year range
$453 / $3.0K
FY2019-FY2023
Trend
-83.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has fluctuated over the past 7 years, ranging from $0 in FY2020 to $19,963 in FY2016.
Based on SEC 10-K filings.
$509 in FY2023 with a 5-year CAGR of -19.9%.
Increased from $453 to $509 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -19.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -19.9%, indicating a declining trend.
- In FY2023, interest expense decreased 83.3% year-over-year.
- Peak interest expense was recorded in FY2016.
- Lowest interest expense in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $509 | -83.3% |
| FY2022 | $3.0K | +572.4% |
| FY2021 | $453 | - |
| FY2020 | $0 | - |
| FY2019 | - | - |
| FY2018 | $1.5K | +29.2% |
| FY2017 | $1.2K | -94.0% |
| FY2016 | $20.0K | -87.1% |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026